OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at OpenAI Blog.
GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
OpenAI launches Rosalind Biodefense, expanding trusted access to GPT-Rosalind for vetted developers and U. S.
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
OpenAI introduces the first research cases showing how GPT-5 accelerates scientific progress across math, physics, biology, and computer science. Explore how AI and researchers collaborate to generate proofs, uncover new insights, and reshape the pace of discovery.
Color Health is working with OpenAI to pioneer a new way of accelerating cancer patients’ access to treatment. Their new Cancer Copilot application uses GPT-4o to identify missing diagnostics and create tailored workup plans, enabling healthcare providers to make evidence-based decisions about cancer screening and treatment.
Consensus uses GPT-5 and OpenAI’s Responses API to power a multi-agent research assistant that reads, analyzes, and synthesizes evidence in minutes—helping over 8 million researchers accelerate scientific discovery.